Search research articles
Contact Us
Filters
Showing results (111-120 of 579) with videos related to
Page
of 58
Sort By:
Frontiers in Immunology
|
October 16, 2018
Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study
Xiaofei Qi, Xuewei Li, Ye Zhao, et al.
International Journal of Hematology
|
July 20, 2022
Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML
Li Wan, Shuqi Ding, Mimi Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
August 26, 2015
[Efficacy observation of tigecycline in the treatment of 107 patients with infection due to granulocytopenia]
Xingxing Hu, Aining Sun, Jiajia Zheng, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation]
Xiebing Bao, Qian Zhu, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 25, 2014
[Clinical characteristics and prognoses of 167 acute erythroleukemia patients]
Wenxiu Cheng, Aining Sun, Suning Chen, et al.
Frontiers in Immunology
|
June 9, 2023
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center
Danqing Kong, Nana Ping, Xin Gao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 14, 2016
[Outcomes of refractory or relapsed DNMT3A + cytogenetically normal acute myeloid leukemia patients followed the therapy including decitabine combined with CAG or CAG-like regimen]
Yanjun Sun, Yang Xu, Depei Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Clinical and laboratory characteristics and treatment option for Philadelphia positive acute lymphoblastic leukemia patients with ABL kinase domain mutations]
Wenzhi Cai, Bin Liu, Yang Xu, et al.
Acta Haematologica
|
August 10, 2023
Sustained Response to Ruxolitinib of Eosinophilia-Associated Myeloproliferative Neoplasm with Translocation t(8;9)(p21;p24)
Ping Cai, Suhui Liu, Lijuan Duan, et al.
Journal of Clinical Medicine
|
October 14, 2023
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
Shiyuan Zhou, Yingying Zhai, Lingzhi Yan, et al.
Page
of 58
Search research articles
Search
Showing results (111-120 of 579) with videos related to
Sort By:
Page
of 58
Frontiers in Immunology
|
October 16, 2018
Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study
Xiaofei Qi, Xuewei Li, Ye Zhao, et al.
International Journal of Hematology
|
July 20, 2022
Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML
Li Wan, Shuqi Ding, Mimi Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
August 26, 2015
[Efficacy observation of tigecycline in the treatment of 107 patients with infection due to granulocytopenia]
Xingxing Hu, Aining Sun, Jiajia Zheng, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation]
Xiebing Bao, Qian Zhu, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 25, 2014
[Clinical characteristics and prognoses of 167 acute erythroleukemia patients]
Wenxiu Cheng, Aining Sun, Suning Chen, et al.
Frontiers in Immunology
|
June 9, 2023
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center
Danqing Kong, Nana Ping, Xin Gao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 14, 2016
[Outcomes of refractory or relapsed DNMT3A + cytogenetically normal acute myeloid leukemia patients followed the therapy including decitabine combined with CAG or CAG-like regimen]
Yanjun Sun, Yang Xu, Depei Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Clinical and laboratory characteristics and treatment option for Philadelphia positive acute lymphoblastic leukemia patients with ABL kinase domain mutations]
Wenzhi Cai, Bin Liu, Yang Xu, et al.
Acta Haematologica
|
August 10, 2023
Sustained Response to Ruxolitinib of Eosinophilia-Associated Myeloproliferative Neoplasm with Translocation t(8;9)(p21;p24)
Ping Cai, Suhui Liu, Lijuan Duan, et al.
Journal of Clinical Medicine
|
October 14, 2023
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
Shiyuan Zhou, Yingying Zhai, Lingzhi Yan, et al.
Page
of 58